Hormones and mammographic breast density

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

2002 • 15,184 citations

Breast cancer and hormone-replacement therapy in the Million Women Study

2003 • 2,896 citations

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

2002 • 1,954 citations

Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women

2003 • 1,839 citations

Body Mass Index, Serum Sex Hormones, and Breast Cancer Risk in Postmenopausal Women

2003 • 1,058 citations

Breast patterns as an index of risk for developing breast cancer

1976 • 907 citations

Mammographic densities and breast cancer risk.

1998 • 804 citations

Heritability of Mammographic Density, a Risk Factor for Breast Cancer

2002 • 589 citations

THE SWEDISH TWO-COUNTY TRIAL TWENTY YEARS LATER

2000 • 463 citations

Postmenopausal Hormone Therapy and Change in Mammographic Density

2003 • 415 citations

Effects of Estrogen and Estrogen–Progestin on Mammographic Parenchymal Density

1999 • 402 citations

European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study: rationale, design and population characteristics

2002 • 379 citations

Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico.

1998 • 372 citations

Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States).

2000 • 359 citations

Tamoxifen and Breast Density in Women at Increased Risk of Breast Cancer

2004 • 328 citations

Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.

1999 • 299 citations

The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial

2004 • 280 citations

The association of breast mitogens with mammographic densities

2002 • 269 citations

Changes in Breast Density Associated With Initiation, Discontinuation, and Continuing Use of Hormone Replacement Therapy

2001 • 257 citations

Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density.

2000 • 252 citations

Effects at Two Years of a Low-Fat, High-Carbohydrate Diet on Radiologic Features of the Breast: Results From a Randomized Trial

1997 • 238 citations

Automated analysis of mammographic densities

1996 • 208 citations

Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern.

1995 • 184 citations

Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density

2002 • 180 citations

Variation in Mammographic Breast Density by Time in Menstrual Cycle Among Women Aged 40-49 Years

1998 • 176 citations

Relationship Between Mammographic and Histological Risk Factors for Breast Cancer

1992 • 174 citations

Tamoxifen and mammographic breast densities.

2000 • 164 citations

Mammographic breast density during hormone replacement therapy: Differences according to treatment

1999 • 160 citations

A volumetric method for estimation of breast density on digitized screen‐film mammograms

2003 • 155 citations

Red clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]

2004 • 153 citations

Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen.

1999 • 141 citations

Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention

2001 • 134 citations

Digitized Mammography: a Clinical Trial of Postmenopausal Women Randomly Assigned to Receive Raloxifene, Estrogen, or Placebo

2001 • 134 citations

Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, The Netherlands

1998 • 121 citations

Reproductive and hormonal factors associated with mammographic breast density by age (United States).

2000 • 114 citations

Effects of mammographic density and benign breast disease on breast cancer risk (United States).

2001 • 105 citations

Serum oestradiol and breast cancer risk.

1999 • 101 citations

Estimation of breast volume and its variation during the menstrual cycle using MRI and stereology.

1999 • 97 citations

Mammographic Tissue, Breast Cancer Risk, Serial Image Analysis, and Digital Mammography

2002 • 89 citations

Mammographic densities in a one-year isoflavone intervention

2003 • 88 citations

The effect of hormone replacement therapy on the sensitivity of screening mammograms

1999 • 84 citations

Case-control study of increased mammographic breast density response to hormone replacement therapy.

2002 • 84 citations

Genetic determinants of mammographic density

2002 • 81 citations

Hormone replacement therapy and the sensitivity and specificity of breast cancer screening: a review

2001 • 79 citations

High-risk mammographic parenchymal patterns, hormone replacement therapy and other risk factors: a case-control study

2000 • 78 citations

Mammographic density changes during the menstrual cycle.

2001 • 74 citations

Use of the American College of Radiology BI-RADS Guidelines by Community Radiologists: Concordance of Assessments and Recommendations Assigned to Screening Mammograms

2002 • 72 citations

Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens

2001 • 70 citations

Mammographic density changes during different postmenopausal hormone replacement therapies

2001 • 64 citations

Impact of menstrual phase on false-negative mammograms in the canadian national breast screening study

1997 • 63 citations

Hormone replacement therapy and the risk of breast cancer. Nested case-control study in a cohort of Swedish women attending mammography screening

1997 • 63 citations

Mammographic changes in postmenopausal women on hormonal replacement therapy

1997 • 63 citations

Gene–environment interactions—the BioBank UK study

2002 • 61 citations

High-risk mammographic parenchymal patterns and anthropometric measures: A case–control study

1999 • 60 citations

Mammographic density changes in perimenopausal and postmenopausal women: is effect of hormone replacement therapy predictable?

2000 • 54 citations

Mammographic Changes in Women Receiving Tibolone Therapy

1998 • 53 citations

Effects of a short-term suspension of hormone replacement therapy on mammographic density

2001 • 52 citations

Mammographic changes associated with raloxifene and tibolone therapy in postmenopausal women: a prospective study

2002 • 52 citations

Mammographic Tissue, Breast Cancer Risk, Serial Image Analysis, and Digital Mammography

2002 • 51 citations

Screening mammography: sensitivity and specificity in relation to hormone replacement therapy.

1997 • 50 citations

Anti-oestrogenic prevention of breast cancer — the make or break point

2002 • 49 citations

Hormone replacement therapy and screening mammography: analysis of the results in the Bouches du Rhône programme

1999 • 48 citations

The effect of hormone replacement therapy on recall rate in the national health service breast screening programme

1997 • 41 citations

Comparison of the effect of raloxifene and continuous-combined hormone therapy on mammographic breast density and breast tenderness in postmenopausal women

2003 • 36 citations

Mammographic density increase in women receiving different hormone replacement regimens

2001 • 36 citations

Mammographic and ultrasonographic study of changes in the breast related to HRT

1999 • 36 citations

Mammographic breast density as a biomarker of effects of isoflavones on the female breast

2001 • 29 citations

Mammographic densities as a criterion for entry to a clinical trial of breast cancer prevention

1995 • 28 citations

Correlates of mammogram density in southwestern Native-American women.

2003 • 27 citations

A pilot study of hormone replacement therapy with tibolone in women with mastopathic breasts

2001 • 23 citations

Can the stroma provide the clue to the cellular basis for mammographic density?

2003 • 23 citations

Breast Cancer Chemoprevention: Current Challenges and a Look Toward the Future

2002 • 22 citations

The effect of various regimens of hormone replacement therapy on mammographic breast density

2003 • 22 citations

Effect of hormone replacement therapy on cancer detection by mammography

1997 • 21 citations

Is a Dense Mammographic Parenchymal Pattern a Contraindication to Hormonal Replacement Therapy?

2000 • 21 citations

Smoking and high-risk mammographic parenchymal patterns: a case-control study

2000 • 20 citations

Effects of hormone replacement therapy on mammographic findings

2003 • 19 citations

New biology of the oestrogen receptor

2003 • 16 citations

Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women.

2002 • 5 citations

Mammographic changes after hormone replacement therapy in patients who have undergone breast irradiation.

1999 • 5 citations